Sequence Bio is launching its first genomics research project this fall in Atlantic Canada to research the genetic makeup of 2,500 volunteering participants in New Brunswick.
By designing one of a kind research studies, we're on our way to better understanding unique genetic populations and discovering better, safer treatments for the diseases that impact us the most.
It is our goal to launch the NL Genome Project, a community-based initiative enabling innovative science, in Newfoundland and Labrador.
Modern drug discovery relies on the right kind of information: real-world patient data that integrates pan-omics with well-characterized phenotypic information. And while this information isn't found everywhere, it is found in Newfoundland and Labrador.
We're always looking for exciting partnerships with companies that understand the value of human genetics as a platform for drug discovery and are willing to share our commitment to the people of Newfoundland and Labrador, so get in touch today!
We're a happy mix from all across Newfoundland and Labrador, with a higher than average affinity for ping-pong. Our kitchen always has some fresh Tetley on the boil and Jam Jam cookies in the cupboard. Get to know us a little more by clicking on our lovely mugs!
We're hiring, join the team
Sequence Bio is planning to conduct research in Newfoundland and Labrador, and doing so in an ethical and transparent way is our first priority. Our research efforts require approval by the Health Research Ethics Board (HREB). The words “believe,” “expect,” “anticipate,” and similar expressions, among others, generally identify our intent and/or objective to undertake research in this province and may be subject to change after HREB Review, and will continue to evolve as our business grows.
Therefore, to ensure full compliance with the process, Sequence Bio will not be sharing any information about planned research studies until approved.